ITC PROPERTIES (00199) and ZHONGMIAO-100 (01471) have signed a framework agreement to jointly explore an innovative business model of "physical asset supply + digital financial security".
Dexiang Real Estate (00199) announced that the group has entered into a framework agreement with Zhongmiao Holdings (01471) and, as of the date of this announcement, has acquired a total of 525,100 shares of Zhongmiao Holdings on the open market to establish a long-term strategic cooperative relationship.
ITC PROPERTIES (00199) announced that the group has entered into a framework agreement with ZHONGMIAO-100 (01471) and as of the date of this announcement, has acquired a total of 525,100 shares of ZHONGMIAO-100 in the open market to establish a long-term strategic partnership.
According to the agreement, both parties will explore an innovative business model of "physical asset supply + digital financial security" through resource integration and technological cooperation, and will cooperate in areas such as digitization of physical assets (RWA), digital asset risk management, and cross-border asset distribution.
The company believes that entering into this agreement aligns with the group's long-term development strategy of promoting asset management and business model innovation. By introducing a partner with expertise in insurance technology and digital risk management, the group can explore the digitization of physical assets and related application scenarios under the premise of compliance, which will help improve asset management efficiency and potential liquidity, and create long-term value for the company and its shareholders.
Related Articles

Huaqin Technology (603296.SH): Hong Kong Stock Exchange considers company's issuance of H shares.

CHINARES PHARMA (03320): China Resources Sanjiu Medical & Pharmaceutical's net profit attributable to shareholders in 2025 is approximately 3.422 billion yuan, an increase of 1.6% year-on-year.

CareRay Digital Medical Technology (688607.SH) plans to increase capital of 70 million yuan to cultivate growth points for Pulse Intelligence.
Huaqin Technology (603296.SH): Hong Kong Stock Exchange considers company's issuance of H shares.

CHINARES PHARMA (03320): China Resources Sanjiu Medical & Pharmaceutical's net profit attributable to shareholders in 2025 is approximately 3.422 billion yuan, an increase of 1.6% year-on-year.

CareRay Digital Medical Technology (688607.SH) plans to increase capital of 70 million yuan to cultivate growth points for Pulse Intelligence.






